# Binhui Biopharmaceutical

Source: https://onco.cc/companies/binhui-biopharmaceutical/  
OnCo record `binhui-biopharmaceutical` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Binhui Biopharmaceutical is a Chinese developer in Wuhan that sponsors 4 registered cancer trials of OH2 and HX008.

## Summary

Binhui Biopharmaceutical appears on ClinicalTrials.gov as the industry sponsor of 4 interventional cancer trials (phase 1/2, 3), testing OH2, HX008 in solid tumor, gastrointestinal cancer, melanoma. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Binhui Biopharmaceutical Co., Ltd.
- Tags: ctgov-sponsor; china; registry-only
- HQ: Wuhan, China
- Type: biotech

## Sources

- ClinicalTrials.gov: trials sponsored by Binhui Biopharmaceutical: https://clinicaltrials.gov/search?spons=Binhui%20Biopharmaceutical

## Connected records

- trials: [OH2 Injection in Combination With BS006 Injection for Advanced Solid Tumors](https://onco.cc/trials/nct07382531/), [OH2 Injection in Combination With HX008 for Melanoma.](https://onco.cc/trials/nct04616443/), [OH2 Injection in Melanoma](https://onco.cc/trials/nct05868707/), [OH2 Oncolytic Viral Therapy in Solid Tumors](https://onco.cc/trials/nct03866525/)

---
JSON: https://onco.cc/api/v1/entities/binhui-biopharmaceutical.json